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LptC is a conserved bitopic inner membrane protein from
Escherichia coli involved in the export of lipopolysaccharide
from its site of synthesis in the cytoplasmic membrane to the
outer membrane. LptC forms a complex with the ATP-binding
cassette transporter, LptBFG, which is thought to facilitate the
extraction of lipopolysaccharide from the inner membrane and
release it into a translocation pathway that includes the putative
periplasmic chaperone LptA. Cysteine modification experi-
ments established that the catalytic domain of LptC is oriented
toward the periplasm. The structure of the periplasmic domain
is described at a resolution of 2.2-A˚ from x-ray crystallographic
data. The periplasmic domain of LptC consists of a twisted boat
structure with two -sheets in apposition to each other. The
-sheets contain seven and eight antiparallel-strands, respec-
tively. This structure bears a high degree of resemblance to the
crystal structure of LptA. Like LptA, LptC binds lipopolysaccha-
ride in vitro. In vitro, LptA can displace lipopolysaccharide from
LptC (but not vice versa), consistent with their locations and
their proposed placement in a unidirectional export pathway.
The outer membrane (OM)3 of Gram-negative bacteria,
such as Escherichia coli, is comprised of an asymmetric lipid
bilayer with phospholipids in the inner leaflet and glycolipids,
predominately lipopolysaccharide (LPS), in the outer leaflet (1).
LPS is an essential component of the OM in most Gram-nega-
tive pathogens, and its unique structural features contribute to
the effective permeability properties of the OM (2–4). In E. coli
and many other Gram-negative bacteria, LPS is composed of
the lipid A moiety, typically a highly conserved diglucosamine-
based phospholipid, that is linked to the long chain polysaccha-
ride known as O-antigen via a core oligosaccharide (5).
The structure and many elements of the biosynthesis of
LPS have been established (reviewed in Refs. 4–6). However,
the precise mechanism(s) of transport and assembly at the
cell surface still remain(s) obscure. The lipid A-core region is
synthesized in consecutive steps at the cytoplasmic face of
the inner membrane (IM) (5) and is exported across the IM by
the ATP-binding cassette (ABC) transporter MsbA (7, 8). O-
antigen is synthesized independently by one of the three differ-
ent pathways and is ligated to the lipid A-core moiety by the
WaaL ligase at the periplasmic face of the IM (5). The complete
LPS molecule then interacts with the LPS transport (Lpt)
machinery (6). It is believed to be extracted from the IM by an
ABCprotein complex comprised of LptB (a predictedABCpro-
tein) (9, 10), LptF (11), LptG (11), and LptC (12, 13). Each of
these proteins is essential for LPS transport and viability in
E. coli. Recent data have established that LptBFGC forms a
stable complex in a 2:1:1:1 stoichiometry (13). Once LPS is
released from the IM, its transit across the periplasm is pro-
posed to be facilitated by LptA, a soluble periplasmic protein
(9). However, the exact mechanism by which LPS is moved
across the periplasm and through the peptidoglycan layer is still
unknown. The final steps in the pathway are attributed to two
OMproteins: LptD, a proteinwith predicted-barrel structure,
and LptE, a lipoprotein (14–17). Both proteins are essential in
E. coli and required for LPS assembly on the cell surface. LptD
and LptE form a stable interaction in a 1:1 complex (16). LptE
also binds LPS in vitro (16).
Twomodels have been proposed for LPS transport across the
periplasm (9, 18). In the first, oligomers of LptA form a protein-
aceous bridge that physically connects the IM and OM, allow-
ing for direct transfer of LPS to the OM. Evidence supporting
this model was provided by the formation of LptA filaments
when crystallized in the presence of LPS (18). In the filament,
LptA monomers interact in a head-to-tail fashion, forming a
linear filament with four monomers constituting one turn of a
left-handed helix (18). The proposal is also consistent with con-
tinued LPS export detected in spheroplasts of E. coli (19). In
addition, the entire Lpt machinery was recently identified in
E. coli membrane fractions that contained markers of both
inner and outermembranes, providing additional evidence that
the Lpt proteins form a trans-envelope complex (20). The sec-
ond model proposes that the LPS export pathway is analogous
to the Lol-mediated lipoprotein transport, and the similarity
* This work was supported by a grant from the Canadian Institutes of Health
Research (to C. W.) and a Wellcome Trust Career Development Fellowship
(to C. D.).
Author’s Choice—Final version full access.
The atomic coordinates and structure factors (code 3MY2) have been deposited
in the Protein Data Bank, Research Collaboratory for Structural Bioinformat-
ics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
□S The on-line version of this article (available at http://www.jbc.org) contains
supplemental Figs. S1 and S2.
1 Both authors contributed equally to this work.
2 The recipient of a Tier 1 Canada Research Chair. To whom correspondence
should be addressed. Tel.: 519-824-4120, Ext. 53361; Fax: 519-837-1802;
E-mail: cwhitfie@uoguelph.ca.
3 The abbreviations used are: OM, outer membrane; IM, inner membrane;
ABC, ATP-binding cassette; TEV, tobacco etch virus; OGM, Oregon green
488 maleimide carboxylic acid; MTSET, methanethiosulfonate ethyltri-
methylammonium; Ni2-NTA, Ni2-nitrilotriacetic acid; SAD, single-wave-
length anomalous dispersion; r.m.s.d., root mean square deviation.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 285, NO. 43, pp. 33529–33539, October 22, 2010
Author’s Choice © 2010 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
OCTOBER 22, 2010•VOLUME 285•NUMBER 43 JOURNAL OF BIOLOGICAL CHEMISTRY 33529
 at Univ of St Andrews, on June 29, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
http://www.jbc.org/content/suppl/2010/09/08/M110.144709.DC1.html 
Supplemental Material can be found at:
between the various components in the two systems is striking.
In the lipoprotein trafficking pathway, LolCDE represents an
ABC protein complex required for the release of nascent
lipoproteins from the IM to a periplasmic chaperone, LolA (21,
22). LolA transfers its cargo to LolB in the OM (23). LptBFG
may be the functional equivalent of LolCDE, but the lipoprotein
export pathway has no obvious component analogous to LptC.
To gain further understanding of the LPS export pathway,
the properties of LptC were investigated. The data reported
here describe the crystal structure of the soluble periplasmic
portion of LptC at 2.2-Å resolution and the structural relation-
ships between LptA and LptC. Like LptA, LptC binds LPS in
vitro, and the results suggest that LptC transfers LPS to LptA in
a unidirectional manner.
MATERIALS ANDMETHODS
Bacterial Strains and Recombinant DNA Techniques—All
bacterial strains and plasmids used in this study are listed in
Table 1. Recombinant DNA and molecular biology techniques
were performed as described previously (24).
Construction of Plasmids—Primers used for cloning are listed
in Table 2. Plasmid pWQ480 was constructed by amplifying
lptC from E. coli W3110 with primers MT5 and MT6 and
cloned into the EcoRI and XbaI sites of pBAD24 (25). The
reverse primer incorporates the sequence for a C-terminal
hexahistidine (His6) tag. Using plasmid pWQ480 as the tem-
plate, single-cysteine derivatives of LptC were made by the
QuikChange site-directedmutagenesis kit (Stratagene) accord-
ing to the manufacturer’s instructions. Primers MT37 and
MT38were used to introduce the codon for a single Cys residue
between codons 1 and 2 of LptC to generate pWQ483. Primers
MT39 andMT40 were used to introduce the codon for a single
cysteine residue between codons 185 and 186 of LptC, generat-
ing pWQ484. A 507-bp DNA fragment, encoding residues
24–191 of LptC (191 residues in total for LptC), was amplified
from W3110 with primers MT30 and MT27 and cloned into
the NdeI and BamHI sites of pET28a (Novagen), producing the
plasmid pWQ481. The absence of the transmembrane helix in
this construct yielded a soluble cytoplasmic protein. The His6-
LptC(24–191) construct includes an N-terminal thrombin/
His6 affinity tag. To facilitate removal of the His6 tag, a version
of LptC(24–191) containing a tobacco etch virus (TEV) prote-
ase recognition site was constructed by amplifying lptC from
W3110 with primersMT28 andMT56. The PCR fragment was
then cloned into the EcoRI and XbaI sites of pBAD24 to gener-
ate the plasmid pWQ482. A removable C-terminal His6-tagged
version of LptA, also containing a TEV protease recognition
site, was constructed by amplifying lptA from W3110 with
primers MT1 and MT55 and cloned into the EcoRI and XbaI
TABLE 1
Bacterial strains and plasmids used in this study
Strain or plasmid Relevant genotype Reference or source
E. coli strains
W3110 Wild type, F,  E. coli Genetic Stock Center (Yale)
XL-1 Blue recA1 endA1 gyrA96thi-1 hsdR17 supE44 relA1 lac (F proAB lacIqZM15::Tn10 (TetR)) Stratagene
Rosetta(DE3)pLysS F ompT hsdSB(rBmB) gal dcm (DE3) pLysSRARE (CamR) Novagen
TOP10 FmcrA (mrr-hsdRMS-mcrBC) 80lacZM15 lacX74 deoR recA1 araD139 (ara-leu)7697
galU galK rpsL Strr endA1 nupG
Invitrogen
CWG904 TOP10 carrying the plasmid, pWQ480; Apr This work
CWG905 Rosetta(DE3)pLysS carrying the plasmid, pWQ481; Kmr This work
CWG906 TOP10 carrying the plasmid, pWQ482; Apr This work
CWG907 TOP10 carrying the plasmid, pWQ483; Apr This work
CWG908 TOP10 carrying the plasmid, pWQ484; Apr This work
CWG909 TOP10 carrying the plasmid, pWQ485; Apr This work
Plasmids
pBAD24 L-Arabinose-inducible plasmid; Apr (25)
pET28a Cloning/expression vector; Kmr Novagen
pWQ480 pBAD24 derivative encoding LptC-His6; Apr This work
pWQ481 pET28a derivative encoding His6-LptC24–191; Kmr This work
pWQ482 pBAD24 derivative encoding LptC24–191-TEV-His6; Apr This work
pWQ483 pBAD24 derivative encoding LptC-His6 with insertion of cysteine (C2); Apr This work
pWQ484 pBAD24 derivative encoding LptC-His6 with insertion of cysteine (C186); Apr This work
pWQ485 pBAD24 derivative encoding LptA-TEV-His6; Apr This work
TABLE 2
Oligonucleotides used for cloning
Primers are 53 3.
Name Sequence Description
MT5 GCGCGCGAATTCACCATGAGTAAAGCCAGACGT FPa: LptC-His6
MT6 GCGCGCTCTAGATCAGTGGTGGTGGTGGTGGTGAGGCTGAGTTTGTTTGTT RP: LptC-His6
MT30 GAGCTACATATGGCCGAAAAAGACGATACC FP: His6-LptC24–191
MT27 GATGCTGGATCCTTAAGGCTGAGTTTGTTT RP: His6-LptC24–191
MT28 CAGGAGGAATTCACCATGAATGATCCCACCTATAAAAGC FP: LptC24–191-TEV-His6
MT56 GCGCGCTCTAGACTAATGATGATGATGATGATGACCCTGAAAATACAGGTTTTCACCGGTACCAGGCTGAGTTTGTTTGTTTTG RP: LptC24–191-TEV-His6
MT37 CAGGAGGAATTCACCATGTGTAGTAAAGCCAGACGTTGGG FP: LptC-His6 (C2)
MT38 CCCAACGTCTGGCTTTACTACACATGGTGAATTCCTCCTG RP: LptC-His6 (C2)
MT39 GAACATCCTATGAAATTCAATGTAACAAACAAACTCAGCC FP: LptC-His6 (C186)
MT40 GGCTGAGTTTGTTTGTTACATTGAATTTCATAGGATGTTC RP: LptC-His6 (C186)
MT1 GCGCGCGAATTCACCATGAAATTCAAAACAAAC FP: LptA-TEV-His6
MT55 GCGCGCTCTAGACTAATGATGATGATGATGATGACCCTGAAAATACAGGTTTTCACCGGTACCATTACCCTTCTTCTGTGCCGG RP: LptA-TEV-His6
a FP, forward primer; RP, reverse primer.
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sites of pBAD24 to generate the plasmid pWQ485. All plasmids
and codon changes were confirmed by DNA sequencing.
Membrane Topology of LptC—The topology of LptC was
determined by site-directed fluorescence labeling of precisely
located Cys residues, following the strategy of Fu and Maloney
(26) with some minor modifications. E. coli strains CWG904,
CWG907, and CWG908 were grown at 37 °C in LB medium
containing 100 g/ml ampicillin for 18 h. Each culture was
diluted 1:100 in 50 ml of fresh medium and grown until mid-
logarithmic phase (A600 0.6). Expression of LptC-His6 from
the pBAD promoter (25) was then induced for 3 h by adding
L-arabinose to a final concentration of 0.2%. Each culture was
divided into three equal aliquots. After harvesting by centrifu-
gation, cells from aliquot one were resuspended in 5 ml of
buffer A (50 mM KH2PO4, pH 8, containing 100 mM K2SO4)
containing freshly prepared Oregon green 488 maleimide car-
boxylic acid (OGM) (40 M) (Molecular Probes Inc.). The cell
suspension was incubated for 20 min at 23 °C before the label-
ing reaction was quenched with -mercaptoethanol (6 mM).
Cells from aliquot two were prepared as described above,
except the cells were labeled with freshly prepared methaneth-
iosulfonate ethyltrimethylammonium (MTSET) (2 mM)
(Toronto Research Chemicals) for 15 min at 23 °C instead of
OGM. Both cell aliquots were then subjected to three cycles of
centrifugation (10,000 g, 10 min) and resuspension/washing
in buffer A. The third aliquot of cell suspension remained
untreated. All three aliquots were resuspended in a lysis solu-
tion (10 mM Tris HCl, pH 7.5, containing 500 g/ml lysozyme,
40 g/ml DNase, and 5 mM EDTA) and incubated at 37 °C for
30min to initiate cell rupture.Membrane ghosts were obtained
by a 10-fold dilution into distilled water, and cytoplasmic pro-
teins were removed by three cycles of centrifugation (10,000
g, 10 min) and membrane resuspension/washing in buffer A.
Membranes obtained from aliquots two and three were resus-
pended with buffer A containing OGM (40M). After a 20-min
incubation at 23 °C, the labeling reactions were quenched by
the addition of -mercaptoethanol (6 mM) and then washed
three times with buffer A. Membranes from all three aliquots
were immediately analyzed by 12%polyacrylamide gels by SDS-
PAGE (27). After electrophoresis, the fluorescence profile from
the SDS-PAGE gel was visualized using the ChemiDoc XRS
system (Bio-Rad), and the protein contents of each lane were
evaluated by staining the same gel with SimplyBlue SafeStain
(Invitrogen).
Purification of His6-LptC(24–191), LptC(24–191)-TEV-His6,
and LptA-TEV-His6—CWG905 was grown at 37 °C in LB con-
taining kanamycin (50g/ml) for 18 h. This culture was diluted
1:100 in fresh medium and grown until mid-logarithmic phase
(A6000.6). Expression of His6-LptC(24–191) was induced for
3 h by adding isopropyl--D-thiogalactopyranoside (IPTG) to a
final concentration of 1 mM. CWG906 was grown in LB con-
taining ampicillin (100 g/ml), and expression of LptC(24–
191)-TEV-His6 was induced with 0.2% L-arabinose for 3 h.
CWG909 was grown at 37 °C in M9 minimal medium contain-
ing ampicillin (100 g/ml) as described previously (24), and
expression of LptA-TEV-His6 was induced with 0.2% L-
arabinose for 1 h. Cells were harvested by centrifugation
(5,000 g, 10 min), resuspended in buffer B (20 mMNaH2PO4,
pH 7.5, containing 300 mM NaCl), and disrupted by passage
through a French press. Unbroken cells and cell debris were
removed by centrifugation (12,000  g, 20 min). The mem-
brane fractionwas removed from the cleared lysate by ultracen-
trifugation (100,000  g, 1 h). Soluble proteins were purified
from the supernatant by using HIS-Select nickel affinity gel
(Sigma) as described previously (24). Elution fractions were
monitored by 12% polyacrylamide gels by SDS-PAGE. The
pooled fractions containing purified protein were desalted by
using a PD-10 column (GEHealthcare), eluted into buffer C (20
mM Tris, pH 7.5, 300 mM NaCl), and finally concentrated by
using a Vivaspin 15R column (10,000 molecular weight cut-off:
Vivascience). Protein concentrations were determined by the
bicinchoninic acid method (28) using bovine serum albumin as
the standard. Removal of the His6 tag using recombinant TEV
protease (Invitrogen) was performed according to the manu-
facturer’s directions.
Analytical Ultracentrifugation—Purified His6-LptC(24–191)
was diluted to 0.75, 0.5, and 0.25 mg/ml in 10 mM Tris buffer, pH
7.5, containing 150mMNaCl. The samples were analyzed using
an Optima XL-1 analytical ultracentrifuge (Beckman Coulter).
Experiments were carried out at 45,000 rpm for 16 h at 16 °C.
Measurements of A280 nm were carried out at 5-min intervals
during the ultracentrifugation.
Crystallization Conditions—Purified His6-LptC(24–191)
was further refined by gel filtration using a HiPrep 16/60
Sephacryl S-100 HR column in buffer C, and the peak fractions
were pooled and concentrated to 20 mg/ml. Screening of pro-
tein crystallization conditions was performed using instrumen-
tation fromCartesian Dispensing Systems (Genomic Solution).
The diamond-shaped crystals took 2 weeks to grow in 0.04 M
K2SO4, 16% PEG 8000, and 20% glycerol at 20 °C, using the
sitting-drop vapor diffusion method with 2 l of protein and 2
l of the crystallization solution. The selenomethionine deriv-
ative of His6-LptC(24–191) was obtained using themethionine
biosynthesis inhibition method (29). Selenomethionine-la-
beled His6-LptC(24–191) was purified as described above in
the presence of 2 mM -mercaptoethanol. The selenomethi-
onine-derivative His6-LptC(24–191) crystals were obtained in
0.04 M K2SO4, 20% PEG 8000, and 20% glycerol after 2 weeks of
incubation at 20 °C, using the same sitting-drop vapor diffusion
method employed for the native protein.
Data Collection and Structure Determination—Selenome-
thionine-labeled His6-LptC(24–191) crystals were protected
by a cryoprotectant containing 20% PEG 8000, 0.04 M K2SO4,
and 25% glycerol, and the data were collected at the Diamond
IO3 Light Source at the peakwavelength of 0.9764Å at100K.
The dataset was indexed, integrated, and scaled using
MOSFLM and Scala (30, 31). The His6-LptC(24–191) crystal
belongs to the space group P43212 with the cell dimensions of
a  b  93.91 Å, c  58.60 Å,       90° with one
monomer of the LptC in an asymmetry unit cell. The phases for
His6-LptC(24–191) were initially calculated at the Diamond
IO3 Light Source using SHELXD (32) and reevaluated using
SOLVE (33) with the single-wavelength anomalous dispersion
(SAD) data. The positions for two selenium atoms were identi-
fied in the asymmetric unit. The phases were improved, and the
initial model was built using RESOLVE (34). The phases from
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2.8 Å were extended to the high resolution (2.2 Å) using DM
(58) and the model was partially built using ARP/wARP (35).
The complete model was built using Coot (36), and structural
refinement was carried out using REFMAC 5 (37). The struc-
ture was evaluated using MolProbity (38).
In Vitro LPS Binding Assay—The in vitro LPS binding as-
says were carried out as described previously (24). The bind-
ing substrate, smooth LPS from E. coli serotype O9a, was
isolated using the hot water-phenol method (39). LPS was
examined by SDS-PAGEand visualized by silver staining (40) as
described previously by Hitchcock and Brown (41). An in vitro
LPS transfer assay was developed based on the assay described
above, and a strategy was used to examine the Lol system (24,
42). Briefly, assays were carried out in 500-l reactions in buffer
C containing 500 g of purified LptA-TEV-His6 or LptC-TEV-
His6 and 150 g of purified O9a LPS. The reactions were incu-
bated at 23 °C for 1 h on a rotary shaker to allow formation of
LPSprotein complexes. HIS-Select nickel affinity gel (Ni2-
NTA resin) (200 l, washed in 1 ml of buffer C; Sigma) was
added to the reaction mixture and incubated for another hour
to facilitate binding of the LPSprotein complexes via the His6
tag. Next, the reaction mixtures were centrifuged at 13,000 g
for 1 min, and the supernatant was collected (designated as FT
in Figs. 2, 5, and 6). The resin was then washed four times
(W1–W4) with buffer C to ensure complete removal of any
unbound LPS, protein, and LPSprotein complexes. Subse-
quently, 500g of TEV-digested (i.e. non-His6-tagged) LptA or
LptC(24–191) was added to the reaction mixture, and incuba-
tion was continued for 1 h at 23 °C. The reaction mixture was
centrifuged again, as described above, and the supernatant was
collected (FT2). The resin was then washed four times (W5–
W8) with 1 ml of buffer C. The remaining immobilized protein
(LptA-TEV-His6 or LptC-TEV-His6) was eluted with 500 l of
buffer C containing 300mM imidazole. A final washwith 500l
of buffer C containing 500 mM imidazole was employed to
ensure that all protein was eluted.
To investigate whether the addition of TEV-digested (non-
His6-tagged) LptA resulted in the transfer of LPS from LptC to
LptA or dissociation of LPS from LptC(24–191), the FT2 frac-
tion was collected in a tube containing an equal amount of
LptA-TEV-His6 (500 g) immobilized on Ni2-NTA resin in
buffer C. The reaction mixture was incubated for 30 min at
23 °C and washed four times with buffer C, and the LptA-TEV-
His6 protein was eluted from theNi2-NTA resin with buffer C
containing 300 mM imidazole, as described above.
RESULTS
Periplasmic Orientation of LptC—Analysis of the primary
sequence of E. coli LptC using the ExPASy tools (43) predicted
a single transmembrane helix (Trp7-Asp29) and a large soluble
domain, consistent with LptC being an IM protein as proposed
previously (12). To probe the topology and orientation of LptC,
an established site-directed fluorescence cysteine-labeling ap-
proach was applied as described previously (26). There are no
native Cys residues in LptC, so single Cys residues were intro-
duced near the N terminus (Cys2) and C terminus (Cys186) by
site-directed mutagenesis.
Three experimental conditions were used during the site-
directed fluorescent labeling (Fig. 1A). In the first condition,
intact cells were labeledwith themembrane-impermeable fluo-
rescent probe, OGM, which will label any exposed Cys-con-
taining proteins exposed outside the IM. After quenching by
-mercaptoethanol, the cells were lysed, andmembrane ghosts
were prepared. In the second condition, intact cells were prein-
cubated with the membrane-impermeable blocking agent,
MTSET, which prevents any subsequent labeling of exposed
Cys residues by OGM. MTSET reagent was removed from the
cell suspension by repeated washes with buffer A prior to the
preparation of membrane ghosts, and then OGM was used to
FIGURE 1. Determination of the topology of LptC. A, the graphic indicates
the predicted OGM accessibility of cysteine derivatives of LptC under three
experimental conditions. B, the fluorescent proteins generated under the
three conditions were separated by SDS-PAGE and are shown. C, to verify
equal expression and loading for eachof the tested LptC constructs, the same
gel was stained with SimplyBlue SafeStain. The arrow to the right of B and C
indicates themigration of LptC. In condition 1, exposed Cys residues in intact
cells were labeled by OGM before a quenching by -mercaptoethanol and
preparation of membrane ghosts. In condition 2, exposed Cys residues were
blocked by preincubation with MTSET, which was removed prior to prepara-
tionofmembraneghosts andOGM labelingofnewly exposedCys residues. In
condition 3, membrane ghosts were labeled directly with OGM.
LptC Is an InnerMembrane Protein Required for LPS Export
33532 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 285•NUMBER 43•OCTOBER 22, 2010
 at Univ of St Andrews, on June 29, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
label any newly exposed cytoplasmic Cys residues. In the final
condition, membrane ghosts were directly treated with OGM,
allowing both periplasmic and cytoplasmic exposed Cys resi-
dues to be labeled. A low level of background fluorescence was
detected in a band co-migrating with LptC in each sample,
including thewild-type protein (inCWG904), which has noCys
residues and provides the negative control. However, specific
labeling yielded a substantially stronger signal. Cys186 was la-
beled in conditions 1 and 3, but not in condition 2, indicating a
periplasmic location (Fig. 1B). In contrast, Cys2 was labeled in
conditions 2 and 3, but not in condition 1, indicating a cytoplas-
mic location. From these results, it is apparent that the N ter-
minus of LptC (and Cys2) is oriented toward the cytoplasm and
the large soluble domain of LptC (and Cys186) is oriented to-
ward the periplasm.
Purification of the Periplasmic Domain of LptC (His6-LptC(24-
191))—The predicted transmembrane domain (Trp7-Asp29) of
LptC is located near the N terminus. Due to the difficulties in
maintaining LptC in a soluble formandpotential complications
associated with crystallizing proteins with transmembrane
regions, we opted to solve the structure of the periplasmic
region of LptC as an alternative to the full-length LptC protein.
Deletion of the first 23 amino acids in His6-LptC(24–191)
yielded a stable soluble form (Fig. 2A, left side, lanes 2 and 4).
Only a minor trace of His6-LptC(24–191) was detected in the
corresponding membrane fractions (Fig. 2B, left side, lanes 3
and 5).
His6-LptC(24–191) was purified to near homogeneity by
Ni2-NTA affinity chromatography, and its identity was veri-
fied by Western immunoblotting with anti-pentahistidine
(His5) monoclonal antibody (Fig. 2, A and B). The migration of
the purified protein on SDS-PAGEwas consistent with the pre-
dicted molecular mass of 21,300 Da. In gel filtration chroma-
tography, His6-LptC(24–191) elutes at the size expected for a
monomer (data not shown). The oligomeric state of purified
His6-LptC(24–191) in solution was confirmed using analytical
ultracentrifugation. In Tris buffer (pH 7.5), the predominant
His6-LptC(24–191) species (95.1% of the loading concentra-
tion) sedimentedwith an s value of 2.6 s and an estimatedmolar
mass of 25.4 kDa (supplemental Fig. S1). This is compatible
with a monomer and consistent with the gel filtration data.
Determination of the Structure of the Periplasmic Domain
of LptC (His6-LptC(24–191))—The crystal structure of the
periplasmic domain of LptC was solved at 2.2-Å resolution
using the SAD method. Data and structural refinement statis-
tics are listed inTable 3. The asymmetric unit contained a single
monomer of LptC. Residues 59–184 were observed in the elec-
FIGURE 2. Cellular localization, purification, and characterization of the
periplasmic domain of LptC. A and B, His6-LptC(24–191) was expressed in
E. coli CWG905. Fractions were separated by SDS-PAGE, and proteins were
visualized using either SimplyBlue SafeStain (A) or Western immunoblotting
with anti-His5 monoclonal antibody (B). The His6-LptC(24–191) construct
migrates as a 21-kDa band (indicated by the arrow on the right), consistent
with the predicted value of 21,300 Da. Lane 1 contains whole cell lysate from
induced E. coli CWG905 cells. Lanes 2 and 4 represent the soluble fractions
after centrifugation at 15,000 and 100,000  g, respectively. Lanes 3 and 5
represent the membrane fractions after centrifugation at 12,000 and
100,000 g, respectively. The purification of His6-LptC(24–191) by Ni
2-NTA
affinity chromatography is shown on the right side of A and B. FT, flow-
through with unbound proteins;W, wash; E, elution with imidazole.
TABLE 3
Data collection and structure validation
Data collection
Wavelength (Å) 0.9764
Resolution (highest shell, Å) 50.90-2.20 (2.26-2.20)
Space group P43212
Cell constants (Å) a 94.21, b 94.21, c 60.44,
   90°
Unique reflections 14,286 (1043)
Average redundancy 6.7 (6.8)
I/ 15.1 (2.3)
Completeness (%) 99.8 (99.9)
Anomalous complete (%)a 99.8 (100)
Rmergeb 0.084 (0.604)
SAD phasing statistics
Selenium ions per assymetric unit 2
Figure of merit (SOLVE 2.8 Å) 0.35
Figure of merit (RESOLVE 2.8 Å) 0.66
Refinement
Rfactor 20.45
Rfree 22.22
r.m.s.d. bonds (Å) / angles (°) 0.011/1.283
B-factor deviationc
Bonds/angles (Å2):
Main chain 0.729/1.118
Side chains 1.832/2.845
Residues in Ramachandran cored (%) 98.39 (1.61% in allowed regions)
Protein atoms 1029
Water atoms 71
Average B-factor (Å2) 40.12
Protein Data Bank accession code 3MY2
Molprobity score 95th percentile
aAnomalous completeness corresponds to the fraction of possible eccentric
reflections generated from the anomalous diffraction in the dataset for which
an anomalous difference has been measured. The anomalous completeness is the
percent of the reflections in the dataset.
bRmergehklIiI	/hkliIi, where Ii is an intensity for the ithmeasurement
of a reflection with indices hkl and I	 is the weighted mean of the reflection
intensity.
c Isotropic thermal factor restraints.
d Thereare tworesidues,Lys162 andGly113, thatarenotat thecoreof theRamachandran
plot, but they are in allowed regions.
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tron density map, but two regions (residues 24–58 and 185–
191) were disordered. The structure of the periplasmic
domain of LptC consists of a twisted boat structure with two
-sheets coming into apposition (Figs. 3A and 7); one
-sheet contains seven antiparallel -strands, and the other
consists of eight antiparallel -strands. The smallest angle
formed between the two -sheets (60°; measured in
PyMOL) occurred at the center of the structure. The largest
angles were observed at the termini (85°), indicating that
the structure of LptC is slightly open at the both ends, similar
to LptA (18) (Figs. 3A and 4). An amino acid sequence align-
ment of E. coli LptA and LptC using ClustalW (44) revealed
a sequence identity score of 4 (less than 10%) between the
two proteins (supplemental Fig. S2A). However, secondary
structural predictions of E. coli LptA and LptC(24–191) (43,
44) indicate that the two proteins have high structural simi-
larities (score  84) (supplemental Fig. S2B). This is consis-
tent with a structural comparison between LptA and
LptC(24–191) using the Dali server (45), which yielded a
Z-score of 15.1 with r.m.s.d. of 2.1 over 117 residues.
FIGURE 3. Structure of the periplasmic domain of LptC. A, a ribbon diagram of a single His6-LptC(24–191) molecule at 2.2-Å resolution. The structure of the
periplasmic domain of LptC is composed of a series of 15 antiparallel-strands thatwind back along the path of the preceding peptide stretch throughout the
length of the protein, resembling the structure of LptA. B, an alignment of the sequences of selected LptC homologues; predicted secondary structure features
are identified. Residue numbering corresponds to LptC fromNeisseriameningitidis (without gaps). Alignmentwas performedwithMultAlin (59). Residueswith
high sequence identity or similarity are shown as colors, and the overall identity (%ID) and similarity (%SIM) are reported. Non-conserved residues are shown
as black letters.
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LptC Binds to LPS in Vitro—We have previously shown that
LptA binds structurally diverse LPS substrates in vitro, and
available data suggest that it interacts specifically with the lipid
A domain of LPS (24). Because LptC has been implicated in LPS
transport and is structurally similar to LptA, the ability of LptC
to bind LPS was investigated using the strategy developed for
LptA. Purified LPS from E. coli serotype O9a was incubated
with purified LptC(24–191)-TEV-His6 or, as a positive control,
purified LptA-TEV-His6. The His6-tagged protein was then
repurified from the reaction mixture by Ni2-NTA affinity
chromatography resin and examined for the presence of bound
LPS. Previous work has already established that purified
LPS does not bind to Ni2-NTA affinity chromatography resin
under these conditions, and LPS binding does not occur with
irrelevant His6-tagged proteins (16, 24, 46). As shown in Fig. 5,
incubating LptC(24–191)-TEV-His6 with LPS resulted in a
substantial amount of LPS bind-
ing, with the complex eluting with
imidazole (Fig. 5, fractions E1 and
E2). The extent of binding was qual-
itatively similar to the LptA-TEV-
His6 control (Fig. 5) and to what we
observed previously with a different
construct, LptA-His6 (24). Like
LptA, LptC also binds smooth LPS
from other serotypes, as well as
rough LPS from E. coliW3110 (data
not shown). This result indicates
that O-antigenic polysaccharide is
not required for substrate recogni-
tion and is consistent with LptC
binding to the hydrophobic domain
of LPS, as has been shown for LptA (24).
Evidence forDirectional Transfer of LPS FromLptC to LptA in
Vitro—Sorting of lipoproteins to the OM requires the ABC
transporter LolCDE, which mediates the detachment of OM-
specific lipoproteins from the IM and delivers them to the
periplasmic carrier protein LolA (21, 22). By analogy, a poten-
tial role of LptC is to facilitate the transfer of LPS from the IM to
a periplasmic chaperone, LptA. To investigate whether LptC
can transfer LPS to LptA, LPS was incubated with LptC-TEV-
His6, and the complex was immobilized in Ni2-NTA affinity
chromatography resin. Unbound or excess LPSmolecules were
removed by repeated washes with buffer C (Fig. 6A,W1–W4).
Purified TEV-digested (non-His6-tagged) LptAwas then added
to the reaction mixture, resulting in the release of substantial
quantities of unbound LPS and LptA in solution (fraction
LptA). After washing the resin with buffer C (W5–W8), the
remaining LptC-TEV-His6LPS was eluted with 300 mM
imidazole (E1–E2). In the converse experiment (Fig. 6B), puri-
fied untagged LptC(24–191) was added to immobilized LptA-
TEV-His6LPS complexes. In this case, no LPS was displaced; it
remained immobilized on the resin and was only eluted (with
LptA-TEV-His6) after the application of 300 mM imidazole
(E1–E2).
These results indicate that LptA can displace LPS from
LptC(24–191)LPS complexes (but not vice versa), consis-
tent with a directionality in the export pathway. To examine
whether the observed effect reflects only displacement, or
transfer of LPS between LptC and LptA, a capture-based
approach was used to distinguish between free and bound LPS
(Fig. 6C). The His6-LptC(24–191)LPS complex was formed
and immobilized on Ni2-NTA resin. Non-His6-tagged LptA
was added to reactionmixture, resulting in a release of LPS and
LptA. This fraction was immediately mixed with LptA-TEV-
His6 that was immobilized onNi2-NTA resin, with the expec-
tation that this would capture any LPSmolecules that were free
in solution. The fractions obtained from washes in buffer C
(W1–W3) and buffer C containing 300 mM imidazole were
examined by SDS-PAGE. The final elution with imidazole
released LptA-TEV-His6 but no LPS, suggesting that the start-
ing material contained no free LPS. The results are consistent
with a transfer of LPS from LptC to LptA, rather than a simple
displacement effect.
FIGURE 4. Structural comparison of LptA and His6-LptC(24–191). Ribbon diagrams of LptA (blue; 2.15 Å)
(Protein Data Bank accession code: 2R19) and His6-LptC(24–191) (green; 2.2 Å) are superimposed.
FIGURE 5. In vitro LPS binding by LptC. The ability of LptA-TEV-His6 or
LptC(24–191)-TEV-His6 to bind to purified O9a LPS was assessed by its co-
elution from Ni2-NTA affinity chromatography resin. LPS was examined by
SDS-PAGE and silver staining (upper) after proteinase K digestion of the elu-
tion fractions. LptA-TEV-His6 and LptC(24–191)-TEV-HIS6 protein in each elu-
tion fraction were also examined by SDS-PAGE and stained with SimplyBlue
SafeStain (lower). FT, flow-through;W, wash in buffer C; E, elution using buffer
C containing 300 mM imidazole.
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DISCUSSION
LPS is an essential component of the OM in most Gram-
negative bacteria, and general aspects of its structure and bio-
synthesis are relatively well understood. In contrast, the com-
ponents involved in LPS transport from the site of biosynthesis
in the IM to the bacterial cell surface have only recently been
identified (9, 11, 12, 15–17, 47), and the precise functions of the
various transport proteins have yet to be resolved. One of the
central questions has been whether the process involves a
periplasmic scaffold formed by LptA and linking the IM com-
ponents (LptBFGC) with those in the OM (LptDE). The alter-
native model invokes LptA as a soluble periplasmic chaperone
in a system showing extensive similarity to the transport of OM
lipoproteins (21, 23, 48, 49). Recent reports support the former
model (20).
LptC is a bitopicmembrane protein that has been implicated
in LPS transport, and, recently, it was shown to be part of a
complex that includes an ABC protein (LptB) as well as two
integral IM proteins (LptFG) (13). The complex is proposed to
be required for LPS extraction of the IM (12). It has been spec-
ulated that LptC serves as the docking site for LptA at the IM
(50). The data reported here do not preclude this scenario.
Although the Lol system lacks an equivalent of LptC, the trans-
fer of LPS cargo from an IM-bound ABC protein complex to a
periplasmic protein resembles the sequence of events in the Lol
system for lipoprotein transport. OM lipoproteins are released
from the IM by an ABC protein complex (LolCDE) in the pres-
ence of a periplasmic chaperone protein, LolA (22). Lipo-
proteins destined for the OM initially bind to LolE, which is
transferred to LolC. LolC then releases the lipoprotein in an
ATP-dependent manner to LolA, which then delivers its cargo
to LolB in the OM (22). The lipoprotein transfer from LolA to
LolB has been shown to occur in a “mouth-to-mouth” manner
(23), and it has been suggested that a similarmodemay exist for
lipoprotein transfer from LolCDE to LolA (22). By comparison,
LPS may be initially released from the IM by LptBFG in an
ATP-dependent process and then transferred via LptC to LptA
in an affinity-driven manner. If this is correct, LptA would
deliver the LPS molecule to the LptDE complex in the OM;
LptE has been demonstrated to bind LPS (16).
The x-ray structure of the periplasmic domain of LptC (at
resolution of 2.2 Å) reveals an overall structure sharing striking
similarities with LptA. Both contain consecutive antiparallel
-strands (15 in LptC and 16 in LptA) that form a twisted boat
structure (Fig. 4). Although LptC and LptA share limited pri-
mary sequence similarities (supplemental Fig. S2A), structural
comparison of the two proteins using the Dali server (45)
revealed a Z-score of 15.1 with an r.m.s.d. of 2.1 for over 117
residues. However, there are some slight differences in the
structures. For example, the opening between the two -sheets
is slightly larger in LptC, and the conformations of the C ter-
mini of the two proteins are different (Fig. 4). TheN terminus of
FIGURE 6. In vitro transfer of LPS from LptC to LptA. A, the dissociation of
O9a LPS from LptC(24–191)-TEV-His6LPS complexes by LptA is shown. The
LptC(24–191)-TEV-His6LPS complex was formed and immobilized on Ni
2-
NTA resin. After washing in buffer C to remove unbound material (W1–W4),
LptA was added, and the eluted material was collected. The remaining resin
was washed in buffer C (W5–W8) followed by buffer C containing 300 mM
imidazole (E1–E2). A sample from each fraction was taken for SDS-PAGE. The
upperpart of eachpanel showsLPS inproteinaseK-digested fractions, stained
by silver nitrate. The lower part shows proteins stained by SimplyBlue
SafeStain. B, in the converse experiment, LptC(24–191)was unable to dissociate
LPS from LptA-TEV-His6LPS. C, the fraction eluted by LptA from LptC(24–
191)-TEV-His6LPS complexes was immediately mixed with resin containing
immobilized LptA-TEV-His6 to capture any free LPS. The resin was washed in
buffer (W1–W3) and buffer containing imidazole (E1–E2). No LptA-TEV-
His6LPS complexes were identified in the capture strategy, suggesting that
LPS remains associated with LptA after its dissociation from LptC(24–191)-
TEV-His6LPS complexes. LPS was examined by SDS-PAGE and silver stain-
ing (upper) after proteinase K digestion of the elution fractions. Proteins in
each elution fraction were also examined by SDS-PAGE and stained with
SimplyBlue SafeStain (lower).
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LptA contains a short -helix that is sandwiched between the
two -sheets (Fig. 4). In contrast, the corresponding N ter-
minus of LptC is disordered. Another notable difference
between the two proteins is that loop 2 in LptC is much
shorter than its counterpart from LptA; however, loop 7
from LptC is much longer than the comparable loop in LptA
(Fig. 4). In the context of similarities between the Lpt and Lol
pathways, it is interesting to note that LolA and LolB, which
provide consecutive lipoprotein binding steps in the path-
way, also share a very similar fold despite limited similarity
FIGURE 7. Ribbon diagrams and surface representations of the conserved hydrophobic residues of LptC. The magenta and green colors represent the
highly conservedhydrophobic residues andnon-conserved residues of LptC, respectively. Hydrophobic residues in the core, aswell as loop7, couldpotentially
adopt different conformations to accommodate LPS binding.
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in their primary sequences (Z-score of 10.6 with an r.m.s.d.
of 3.2 over 134 residues) (48).
Mammalian LPS-binding proteins such as MD-2 and CD14
have a similar binding cavity size (15  8  10 Å) (51), and
co-crystal structures are available for MD-2 with bound lipid
IVA, or the mimic compound, eritoran (52, 53). Well defined
substrate-binding pockets are also evident in LolA and LolB
(23, 51, 52). In contrast, the structures of LptA and LptC do not
reveal an obvious cavity on their surfaces that is deep enough to
accommodate the fatty acyl chains of lipid A. LptC does possess
many conserved hydrophobic residues that formahydrophobic
core along the protein that could potentially serve as an LPS-
binding site (Figs. 3B and 7). Ribbon and surface representa-
tions of LptC both demonstrate that most of the conserved
hydrophobic residues are oriented toward the interior cavity
of the protein (Fig. 7). The protein would presumably need to
undergo a conformational change to form an internal binding
pocket for lipid A, and that pocket would also have to accom-
modate the side chains of the hydrophobic amino acid residues
(Fig. 7). Local rearrangements that result in possible LPS-bind-
ing sites are also feasible (Fig. 7). For example, all of the residues
in loop 7 (residues 86–92) (Fig. 7 and supplemental Fig. S2D)
have B-factors ranging from 50 to 60, whereas neighboring
residues have B-factors that range only from 30 to 40. Inter-
estingly, this loop region shares limited homology (ClustalW
(44) score  21) to the peptide LPS antagonist LBP-14
(RVQGRWKVRASFFK), a synthetic fragment derived from the
LPS-binding protein that has been shown to interact with LPS
(54) (supplemental Fig. S2D). The functional significance of this
similarity remains unclear. Recent isolation of a temperature-
sensitivemutant ofE. coli, designatedMB2, revealed two amino
acid substitutions (V60D and V132A) in LptA, as well as the
addition of two amino acid substitutions (S44R and M108R) in
LptC (55). However, only the expression of LptA was able to
rescue this mutant at 44 °C (55). V132A is located in loop 5 of
LptA; however, V60D is located near a region that also shares
homology to LBP-14 (ClustalW (44) score  21), as well as to
the loop 7 region of LptC (Fig. 4 and supplemental Fig. S2C).
Several hydrophobic residues located in loop 7 are exposed in
LptC, Phe86, Ile91, and Pro92, indicating that loop 7may play an
important role in LPS binding (Fig. 7 and supplemental Fig.
S2D). However, additional mutagenesis and structural studies
of LptC are needed to determine the important residues
required for LPS binding. Ultimately, this question can only be
resolved by a crystal structure of LptC (or LptA) with bound
LPS. Unfortunately, attempts to crystallize the complexes have,
so far, been unsuccessful.
The model for LPS transport that invokes an LptA-con-
taining periplasmic bridge is heavily influenced by the fila-
ments of LptA oligomers obtained from crystallization con-
ditions that included LPS (Protein Data Bank accession code:
2R1A) (18). In our hands, LptA behaves as a monomer in solu-
tion, but the localization of LptA and (potentially) its oligo-
meric status may be influenced by the level of expression (20).
We were able to obtain one crystal form of LptA with four
molecules in the asymmetric unit (data not shown). The four
LptA molecules in the asymmetric unit were organized as two
sets of dimers arranged in a head-to-tail fashion as reported
previously (18), and its structure is superimposable with the
reported structure of LptA (Protein Data Bank accession code:
2R19) (Z-score of 23.9with r.m.s.d. of 1.2 for over 133 residues).
Interestingly, for reconstruction of the crystal lattice of both
LptA structures (our data and the previously reported structure
(2R19)), which were grown in the absence of LPS, we observed
LptA molecules arranged in a head-to-tail fashion, resembling
the eight-molecule (filamentous) form of LptA (2R1A) previ-
ously reported to only be induced in the presence of LPS (18).
Thus, it is possible that the chain-like arrangements of LptA
monomers previously observed for 2R1A are not exclusively
dependent on LPS but are the result of crystal packing. How-
ever, we have been unable to detect the eight-molecule form of
LptA (or any higher order complexes) in solution using size
exclusion chromatography, regardless of the presence or
absence of added LPS. There is support from protein localiza-
tion (16) and spheroplast (19) experiments for the “scaffold”
assembly model. However, under the experimental conditions
used here, we were unable to detect any stable interactions
between the LptC and LptA derivatives in pulldown experi-
ments (data not shown). Collectively, the current protein struc-
ture data cannot unequivocally distinguish between either of
the proposed assembly models.
The essential requirement for LPS in many bacteria, includ-
ing prominent Gram-negative pathogens (3–5), as well as the
periplasmic location of much of the transport machinery,
suggests that the Lpt pathway may be an interesting poten-
tial target for new therapeutic interventions. Interestingly,
bioinformatic surveys and examination of the COGs (Clusters
of Orthologous Groups of proteins) database (56, 57) indicate
that not all components of the pathway are conserved in other
bacteria. Several bacterial species lack a structural gene for lptC;
examples include Helicobacter pylori, Campylobacter jejuni,
Mesorhizobium loti, Caulobacter crescentus, Aquifex aeolicus,
Thermotoga maritima, Deinococcus radiodurans, Rickettsia
prowazekii, Chlamydia trachomatis, Treponema pallidum, and
Borrelia burgdorferi. Interestingly, these same organisms do
not have homologues of lptE. Presumably in these organisms,
LptBFG delivers LPS directly to LptA, which then delivers
directly to the OM -barrel protein, LptD (16, 50). Regardless,
although many components of the LPS machinery are con-
served, there may be subtle variations in the process across
Gram-negative bacteria.
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